Myriad Genetics Inc
XBER:MYD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Myriad Genetics Inc
XBER:MYD
|
US |
|
T
|
TriNet Group Inc
F:TN3
|
US |
|
C
|
CBRE Group Inc
DUS:RF6
|
US |
|
TechnipFMC PLC
NYSE:FTI
|
UK |
|
CTS Corp
NYSE:CTS
|
US |
|
W
|
World Kinect Corporation
NYSE:WKC
|
US |
|
Doxee SpA
MIL:DOX
|
IT |
|
M
|
Medline Inc
NASDAQ:MDLN
|
US |
|
D
|
Dover Corp
F:DOV
|
US |
|
Kimberly-Clark de Mexico SAB de CV
BMV:KIMBERA
|
MX |
|
Transocean Ltd
NYSE:RIG
|
CH |
|
GomSpace Group AB
F:1G2
|
SE |
|
L
|
Lamar Advertising Co
F:6LA
|
US |
|
M
|
Mitsui Fudosan Co Ltd
XMUN:MFU
|
JP |
|
Bentley Systems Inc
F:BS81
|
US |
|
N
|
New York Times Co
DUS:NYT
|
US |
|
Easterly Government Properties Inc
NYSE:DEA
|
US |
|
C
|
Cerner Corp
LSE:0R00
|
US |
|
N
|
Noah Holdings Ltd
F:6NO
|
CN |
|
Bioretec Oy
F:0TN
|
FI |
|
Canadian Pacific Railway Ltd
TSX:CP
|
CA |
|
Telefonica SA
NYSE:TEF
|
ES |
|
C
|
Chimera Investment Corp
F:4CR1
|
US |
|
Occidental Petroleum Corp
BMV:OXY1
|
US |
Bankruptcy Probability
Myriad Genetics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Myriad Genetics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Myriad Genetics Inc
NASDAQ:MYGN
|
321.2m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
450.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
206.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
179.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
80B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Myriad Genetics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Myriad Genetics Inc has total debt of 120.7m USD. This includes both short-term (0 USD) and long-term (120.7m USD) debt.
You can find a full breakdown on its Balance Sheet.
